District Court Interprets EKRA
FDA Law Blog
JANUARY 6, 2022
220 and was described on HP&M’s blog here. S&G Labs alleged during the litigation that they are paid on a “per test” basis by third party insurers, government agencies under the Medicare and Medicaid programs, and direct “self-pay” by some individuals. EKRA is codified at 18 U.S.C. § Graves , 2021 U.S. LEXIS 29248, at *2-3 (D.
Let's personalize your content